Detalhe da pesquisa
1.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med
; 20(1): 136, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462552
2.
TIM-4 glycoprotein-mediated degradation of dying tumor cells by autophagy leads to reduced antigen presentation and increased immune tolerance.
Immunity
; 39(6): 1070-81, 2013 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315994
3.
Polymorphonuclear Myeloid-Derived Cells That Contribute to the Immune Paralysis Are Generated in the Early Phase of Sepsis via PD-1/PD-L1 Pathway.
Infect Immun
; 89(6)2021 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753411
4.
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
Breast Cancer Res Treat
; 188(1): 117-131, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33763789
5.
The efficacy and safety of pertuzumab plus trastuzumab and docetaxel as a first-line therapy in Japanese patients with inoperable or recurrent HER2-positive breast cancer: the COMACHI study.
Breast Cancer Res Treat
; 185(1): 125-134, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920732
6.
Tolerogenic properties of CD206+ macrophages appeared in the sublingual mucosa after repeated antigen-painting.
Int Immunol
; 32(8): 509-518, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32128565
7.
Orthotopic tongue squamous cell carcinoma (SCC) model exhibiting a different tumor-infiltrating T-cell status with margin-restricted CD8+ T cells and regulatory T cell-dominance, compared to skin SCC.
Biochem Biophys Res Commun
; 526(1): 218-224, 2020 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32204917
8.
HIF1α inhibits LPS-mediated induction of IL-6 synthesis via SOCS3-dependent CEBPß suppression in human dental pulp cells.
Biochem Biophys Res Commun
; 522(2): 308-314, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767145
9.
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.
Invest New Drugs
; 38(1): 140-147, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289984
10.
Fabrications of boron-containing apatite ceramics via ultrasonic spray-pyrolysis route and their responses to immunocytes.
J Mater Sci Mater Med
; 31(2): 20, 2020 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31965347
11.
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patients.
Br J Cancer
; 120(5): 475-480, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745582
12.
Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model.
Biochem Biophys Res Commun
; 518(2): 331-336, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31421832
13.
The CD28-B7 Family of Co-signaling Molecules.
Adv Exp Med Biol
; 1189: 25-51, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31758530
14.
BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
Genes Chromosomes Cancer
; 56(5): 405-420, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28124401
15.
PI3K-Akt pathway enhances the differentiation of interleukin-27-induced type 1 regulatory T cells.
Immunology
; 152(3): 507-516, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685820
16.
TGF-ß-induced phosphorylation of Akt and Foxo transcription factors negatively regulates induced regulatory T cell differentiation.
Biochem Biophys Res Commun
; 480(1): 114-119, 2016 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27697523
17.
Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells.
Genes Cells
; 18(4): 247-65, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23383714
18.
The Japanese Breast Cancer Society Clinical Practice Guidelines for Breast Cancer, 2022 Edition: changes from the 2018 edition and general statements on breast cancer treatment.
Breast Cancer
; 31(3): 340-346, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38570435
19.
Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study.
Breast Cancer
; 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642245
20.
Trastuzumab deruxtecan for human epidermal growth factor receptor 2-low advanced or metastatic breast cancer: recommendations from the Japanese Breast Cancer Society Clinical Practice Guidelines.
Breast Cancer
; 31(3): 335-339, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433181